Kalinsky, Kevin http://orcid.org/0000-0002-1583-3553
Accordino, Melissa K.
Hosi, Kristina
Hawley, Jessica E.
Trivedi, Meghna S.
Crew, Katherine D.
Hershman, Dawn L.
Article History
Received: 23 April 2020
Accepted: 5 May 2020
First Online: 14 May 2020
Compliance with ethical standards
:
: No conflicts are related to this particular study. For unrelated conflictions, Kevin Kalinsky served as a consultant/advisory board member for Immunomedics, Biotheranostics, Pfizer, Novartis, Eisai, Eli-Lilly, Amgen, and AstraZeneca. He has received institutional grants from Immunomedics, Novartis, Incyte, Genentech/Roche, Eli-Lilly, Pfizer, Calithera Biosciences, Acetylon, Seattle Genetics, Amgen, Zentalis Pharmaceuticals, and CytomX Therapeutics. Served on speakers’ bureau for Eli-Lilly. Received travel expenses from Lilly and Astra Zeneca. Spouse was previously employed by Novartis, Array Biopharma, and Pfizer.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
Free to read: This content has been made available to all.